Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many companies are licensed to sell cannabis products to the NHS.

Any company meeting the standards for the manufacture of unlicensed medicinal products, can supply cannabis-based products for medicinal use.

Cannabis-based products for medicinal use are Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001, which means that manufacturers, importers and distributors of these products must hold valid Home Office and Medicines and Healthcare products Regulatory Agency (MHRA) licences for the relevant activities which will include possession, supply and production of controlled drugs. Where products are sourced from abroad, importers must obtain an import licence from the Home Office and non-objection to import from the MHRA for each individual import of a controlled drug.